3rd Quarter - Report

NOVAVAX, INC for NOVAVAX, INC

Firm
Client
Income
—
Expenses
$50,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Vaccine Policy - Medicare

LobbyistCovered position, as disclosed
KELLY CAPPIO —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Vaccine Policy - H.R. 6, 21st Century Cures Act; S. 2742, Promoting Biomedical Research and Public Health for Patients Act

LobbyistCovered position, as disclosed
KELLY CAPPIO —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2742 (114th), H.R. 6 (114th)

Budget/Appropriations BUD

H.R. 5325, Zika Response and Preparedness Act

LobbyistCovered position, as disclosed
KELLY CAPPIO —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5325 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.